tripotassium;7-(1,3-dioxoisoindol-2-yl)-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;methyl 2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;7-[[2-[3-(3-oxo-4H-1,4-benzoxazin-6-yl)propanoyl]benzoyl]amino]-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;dihydroxide

C91H66K3N19O22-2 — CID 157473523

IUPACtripotassium;7-(1,3-dioxoisoindol-2-yl)-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;methyl 2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;7-[[2-[3-(3-oxo-4H-1,4-benzoxazin-6-yl)propanoyl]benzoyl]amino]-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;dihydroxide
SMILESCOC(=O)c1ccccc1C(=O)Nc1c[nH]c2c([C-]=O)ncnc12.O=C1COc2ccc(CNC(=O)c3ncnc4c(N5C(=O)c6ccccc6C5=O)c[nH]c34)cc2C1.O=C1COc2ccc(CNC(=O)c3ncnc4c(NC(=O)c5ccccc5C(=O)CCc5ccc6c(c5)NC(=O)CO6)c[nH]c34)cc2C1.O=[C-]c1ncnc2c(NC(=O)c3ccccc3C(=O)[O-])c[nH]c12.[K+].[K+].[K+].[OH-].[OH-]
InChIInChI=1S/C35H28N6O7.C25H17N5O5.C16H11N4O4.C15H9N4O4.3K.2H2O/c42-22-13-21-11-20(7-9-28(21)47-16-22)14-37-35(46)33-32-31(38-18-39-33)26(15-36-32)41-34(45)24-4-2-1-3-23(24)27(43)8-5-19-6-10-29-25(12-19)40-30(44)17-48-29;31-15-8-14-7-13(5-6-19(14)35-11-15)9-27-23(32)22-21-20(28-12-29-22)18(10-26-21)30-24(33)16-3-1-2-4-17(16)25(30)34;1-24-16(23)10-5-3-2-4-9(10)15(22)20-11-6-17-14-12(7-21)18-8-19-13(11)14;20-6-11-13-12(18-7-17-11)10(5-16-13)19-14(21)8-3-1-2-4-9(8)15(22)23;;;;;/h1-4,6-7,9-12,15,18,36H,5,8,13-14,16-17H2,(H,37,46)(H,40,44)(H,41,45);1-7,10,12,26H,8-9,11H2,(H,27,32);2-6,8,17H,1H3,(H,20,22);1-5,7,16H,(H,19,21)(H,22,23);;;;2*1H2/q;;2*-1;3*+1;;/p-3
InChIKeyCGGDQIHEFLICHK-UHFFFAOYSA-K
MW1894.93 g/mol
LogP-1.87
Rot. Bonds21

About tripotassium;7-(1,3-dioxoisoindol-2-yl)-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;methyl 2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;7-[[2-[3-(3-oxo-4H-1,4-benzoxazin-6-yl)propanoyl]benzoyl]amino]-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;dihydroxide

tripotassium;7-(1,3-dioxoisoindol-2-yl)-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;methyl 2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;7-[[2-[3-(3-oxo-4H-1,4-benzoxazin-6-yl)propanoyl]benzoyl]amino]-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;dihydroxide (PubChem CID 157473523) has the molecular formula C91H66K3N19O22-2 and a molecular weight of 1894.93 g/mol. Its IUPAC name is tripotassium;7-(1,3-dioxoisoindol-2-yl)-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;methyl 2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;7-[[2-[3-(3-oxo-4H-1,4-benzoxazin-6-yl)propanoyl]benzoyl]amino]-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;dihydroxide.

Molecular Properties

Compound Nametripotassium;7-(1,3-dioxoisoindol-2-yl)-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;methyl 2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;7-[[2-[3-(3-oxo-4H-1,4-benzoxazin-6-yl)propanoyl]benzoyl]amino]-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;dihydroxide
PubChem CID157473523
Molecular FormulaC91H66K3N19O22-2
Molecular Weight1894.93 g/mol
Exact Mass1893.36
IUPAC Nametripotassium;7-(1,3-dioxoisoindol-2-yl)-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;methyl 2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;7-[[2-[3-(3-oxo-4H-1,4-benzoxazin-6-yl)propanoyl]benzoyl]amino]-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;dihydroxide
SMILESCOC(=O)c1ccccc1C(=O)Nc1c[nH]c2c([C-]=O)ncnc12.O=C1COc2ccc(CNC(=O)c3ncnc4c(N5C(=O)c6ccccc6C5=O)c[nH]c34)cc2C1.O=C1COc2ccc(CNC(=O)c3ncnc4c(NC(=O)c5ccccc5C(=O)CCc5ccc6c(c5)NC(=O)CO6)c[nH]c34)cc2C1.O=[C-]c1ncnc2c(NC(=O)c3ccccc3C(=O)[O-])c[nH]c12.[K+].[K+].[K+].[OH-].[OH-]
InChIInChI=1S/C35H28N6O7.C25H17N5O5.C16H11N4O4.C15H9N4O4.3K.2H2O/c42-22-13-21-11-20(7-9-28(21)47-16-22)14-37-35(46)33-32-31(38-18-39-33)26(15-36-32)41-34(45)24-4-2-1-3-23(24)27(43)8-5-19-6-10-29-25(12-19)40-30(44)17-48-29;31-15-8-14-7-13(5-6-19(14)35-11-15)9-27-23(32)22-21-20(28-12-29-22)18(10-26-21)30-24(33)16-3-1-2-4-17(16)25(30)34;1-24-16(23)10-5-3-2-4-9(10)15(22)20-11-6-17-14-12(7-21)18-8-19-13(11)14;20-6-11-13-12(18-7-17-11)10(5-16-13)19-14(21)8-3-1-2-4-9(8)15(22)23;;;;;/h1-4,6-7,9-12,15,18,36H,5,8,13-14,16-17H2,(H,37,46)(H,40,44)(H,41,45);1-7,10,12,26H,8-9,11H2,(H,27,32);2-6,8,17H,1H3,(H,20,22);1-5,7,16H,(H,19,21)(H,22,23);;;;2*1H2/q;;2*-1;3*+1;;/p-3
InChIKeyCGGDQIHEFLICHK-UHFFFAOYSA-K
XLogP-1.87
TPSA617.73 Ų
H-Bond Donors10
H-Bond Acceptors30
Rotatable Bonds21
Heavy Atoms135
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001894.93
LogP ≤ 5-1.87
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze tripotassium;7-(1,3-dioxoisoindol-2-yl)-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;methyl 2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;7-[[2-[3-(3-oxo-4H-1,4-benzoxazin-6-yl)propanoyl]benzoyl]amino]-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;dihydroxide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tripotassium;7-(1,3-dioxoisoindol-2-yl)-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;methyl 2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;7-[[2-[3-(3-oxo-4H-1,4-benzoxazin-6-yl)propanoyl]benzoyl]amino]-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;dihydroxide?
The IUPAC name of tripotassium;7-(1,3-dioxoisoindol-2-yl)-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;methyl 2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;7-[[2-[3-(3-oxo-4H-1,4-benzoxazin-6-yl)propanoyl]benzoyl]amino]-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;dihydroxide (CID 157473523) is tripotassium;7-(1,3-dioxoisoindol-2-yl)-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;methyl 2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;7-[[2-[3-(3-oxo-4H-1,4-benzoxazin-6-yl)propanoyl]benzoyl]amino]-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;dihydroxide.
What is the SMILES notation for tripotassium;7-(1,3-dioxoisoindol-2-yl)-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;methyl 2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;7-[[2-[3-(3-oxo-4H-1,4-benzoxazin-6-yl)propanoyl]benzoyl]amino]-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;dihydroxide?
The canonical SMILES for tripotassium;7-(1,3-dioxoisoindol-2-yl)-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;methyl 2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;7-[[2-[3-(3-oxo-4H-1,4-benzoxazin-6-yl)propanoyl]benzoyl]amino]-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;dihydroxide is COC(=O)c1ccccc1C(=O)Nc1c[nH]c2c([C-]=O)ncnc12.O=C1COc2ccc(CNC(=O)c3ncnc4c(N5C(=O)c6ccccc6C5=O)c[nH]c34)cc2C1.O=C1COc2ccc(CNC(=O)c3ncnc4c(NC(=O)c5ccccc5C(=O)CCc5ccc6c(c5)NC(=O)CO6)c[nH]c34)cc2C1.O=[C-]c1ncnc2c(NC(=O)c3ccccc3C(=O)[O-])c[nH]c12.[K+].[K+].[K+].[OH-].[OH-].
What is the InChIKey of tripotassium;7-(1,3-dioxoisoindol-2-yl)-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;methyl 2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;7-[[2-[3-(3-oxo-4H-1,4-benzoxazin-6-yl)propanoyl]benzoyl]amino]-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;dihydroxide?
The InChIKey is CGGDQIHEFLICHK-UHFFFAOYSA-K. The full InChI is InChI=1S/C35H28N6O7.C25H17N5O5.C16H11N4O4.C15H9N4O4.3K.2H2O/c42-22-13-21-11-20(7-9-28(21)47-16-22)14-37-35(46)33-32-31(38-18-39-33)26(15-36-32)41-34(45)24-4-2-1-3-23(24)27(43)8-5-19-6-10-29-25(12-19)40-30(44)17-48-29;31-15-8-14-7-13(5-6-19(14)35-11-15)9-27-23(32)22-21-20(28-12-29-22)18(10-26-21)30-24(33)16-3-1-2-4-17(16)25(30)34;1-24-16(23)10-5-3-2-4-9(10)15(22)20-11-6-17-14-12(7-21)18-8-19-13(11)14;20-6-11-13-12(18-7-17-11)10(5-16-13)19-14(21)8-3-1-2-4-9(8)15(22)23;;;;;/h1-4,6-7,9-12,15,18,36H,5,8,13-14,16-17H2,(H,37,46)(H,40,44)(H,41,45);1-7,10,12,26H,8-9,11H2,(H,27,32);2-6,8,17H,1H3,(H,20,22);1-5,7,16H,(H,19,21)(H,22,23);;;;2*1H2/q;;2*-1;3*+1;;/p-3.
What are the key properties of tripotassium;7-(1,3-dioxoisoindol-2-yl)-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;methyl 2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;7-[[2-[3-(3-oxo-4H-1,4-benzoxazin-6-yl)propanoyl]benzoyl]amino]-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;dihydroxide?
tripotassium;7-(1,3-dioxoisoindol-2-yl)-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;methyl 2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;7-[[2-[3-(3-oxo-4H-1,4-benzoxazin-6-yl)propanoyl]benzoyl]amino]-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;dihydroxide has a molecular weight of 1894.93 g/mol, XLogP of -1.87, 21 rotatable bonds, 10 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for tripotassium;7-(1,3-dioxoisoindol-2-yl)-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;methyl 2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;7-[[2-[3-(3-oxo-4H-1,4-benzoxazin-6-yl)propanoyl]benzoyl]amino]-N-[(3-oxo-4H-chromen-6-yl)methyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide;2-[[4-(oxomethyl)-5H-pyrrolo[3,2-d]pyrimidin-7-yl]carbamoyl]benzoate;dihydroxide is sourced from PubChem (CID 157473523), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).